GlassScriptPhysician profile
John Joseph Schilling
NPI 1841282142
$325.50
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $41.78 · 2021: $26.53 · 2022: $62.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $180.14 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.15 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.18 | 2019 | |
| Lupin INC. | $19.74 | 2020 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2021 | |
| Boston Scientific Corporation | $15.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.74 | 2019 | |
| Travere Therapeutics, INC. | $6.84 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schilling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.